Cite
HARVARD Citation
Macaluso, F. et al. (n.d.). P345 The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease. Journal of Crohn's and colitis. pp. i359-i360. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Macaluso, F. et al. (n.d.). P345 The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease. Journal of Crohn's and colitis. pp. i359-i360. [Online].